BFRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Biofrontera Inc (BFRI) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance shows significant declines in net income and EPS despite revenue growth, and there are no positive catalysts or trading signals to suggest immediate upside potential. It is better to hold off on investing in this stock until clearer positive trends emerge.
The technical indicators for BFRI are bearish. The MACD is negative and expanding downward, the RSI is neutral at 30.722, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its S1 support level of 0.796, with resistance levels at 0.865 and 0.933. Overall, the technical outlook suggests a downward trend.
There are no recent news events or significant positive catalysts for BFRI. Hedge funds and insiders are neutral, with no significant trading trends.
is also down by -1.79%. Financial performance shows a significant drop in net income (-504.01% YoY) and EPS (-100% YoY), which are negative indicators for long-term growth.
In Q4 2025, revenue increased by 36.16% YoY to $17.1 million, and gross margin improved by 42.02% YoY to 82.4%. However, net income dropped by -504.01% YoY to -$5.64 million, and EPS fell to 0, down -100% YoY. This indicates significant profitability challenges despite revenue growth.
No recent analyst ratings or price target changes are available for BFRI.
